Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discounts will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
The drug delivery and development services firm Catalent has agreed to acquire Juniper Pharmaceuticals for $133 million. Juniper’s pharma services division offers drug industry customers solid-state and preclinical formulation screening as well as bioavailability enhancement technologies. Catalent says Juniper’s Nottingham, England, facility will be a European complement to its drug development centers in Somerset, N.J. and San Diego.
This article has been sent to the following recipient: